We assessed the reliability and validity of the Turkish version of the seven-item Panic Disorder Severity Scale (PDSS). We recruited 174 subjects, including 104 with current DSM-IV panic disorder with (n=76) or without(n=28)agoraphobia, 14 with a major depressive episode, 24 with a non-panic anxiety disorder, and 32 healthy controls. Assessment instruments were Panic Disorder Severity Scale, Panic and Agoraphobia Scale, both the observer-rated (P&Ao) and self-rating (P& Asr); Clinical Global Impression Scale (CGI); Hamilton Anxiety Scale, and Beck Depression Inventory. We repeated the measures for a group of panic disorder patients (n = 51) after 4 weeks to assess test-retest reliability. The internal consistency (Cronbach's alpha) of the PDSS was .92-94. The inter-rater correlation coefficient was .79. The test-retest correlation coefficient after 4 weeks was .63. In discriminant validity analyses, the highest correlation for PDSS was with P&Ao, P&Asr (r=.87 and.87, respectively) and CGI (r=.76) and the lowest with Beck Depression Inventory (r=.29). The cut-off point was six/seven, associated with high sensitivity (99%) and specificity (98%). This study confirmed the objectivity, reliability and validity of the Turkish version of the PDSS.
This study has two objectives: One is to demonstrate the Likert-type response scale generation for the Turkish version of the WHOQOL. The other is to show the effect of level of education of the subjects to translate their perception into a rating on a Visual Analog Scale (VAS). WHOQOL questions have four types of response scales: frequency, evaluation, capacity, and intensity. The WHOQOL cross-cultural response scale methodology is based on the VAS. Fifty-one low-level educated subjects from the initial study population (n = 228) were excluded by applying two special exclusion criteria, because of the reliability problems. Those subjects with 8 years and less education were more likely than those with 11 years' (OR = 0.25%; 95 CI 0.11-0.56) and 15 years' and more education (OR = 0.11; 95% CI 0.04-0.29) to be excluded from the study. After translating anchor points into Turkish, the VAS were prepared for each of the response scales (intensity, capacity, frequency, and evaluation). A list of descriptors—16 for frequency, 15 for capacity and intensity, 16 and 14 for evaluation scales—were compiled from dictionaries and the relevant literature. Each descriptor was placed on a 10 cm fresh line in a random order in every scale. The study subjects were asked to place a mark on a 10 cm line for each descriptor, according to where they think the descriptor lies in relation to the anchor points. In order to select the intermediate descriptors for each scale, mean distances for each descriptor were calculated and target intermediate descriptors were found for each scale by applying WHOQOL response scale methodology. The intra-class correlation coefficients (ICC), which indicate the interrater reliability in the current setting, were calculated in the included study population (n = 177) for each education category separately. ICCs were found as 0.39 for 5 years', 0.46 for 8 years', 0.66 for 11 years', and 0.79 for 15 years' and more education categories. Categories of at least 11 years' education were found to show sufficient interrater reliability. The mean and the variabilities of the target descriptors produced similar results with the initial 15 WHOQOL centers. On the other hand, the obtained results indicate that visual analog scale methodology should be used with caution on subjects educated less than 9 years in the Turkish context.
Comparative efficacy of c-pharm early and late strategies in providing improved protection against post-ECT relapse of major depressive disorder needs to be further explored.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.